Suppr超能文献

下调 miR-27a 可能逆转食管鳞癌细胞的多药耐药性。

Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma.

机构信息

Xijing Hospital of Digestive Diseases, Fourth Military Medical University, 710032, Xi'an, Shaanxi Province, China.

出版信息

Dig Dis Sci. 2010 Sep;55(9):2545-51. doi: 10.1007/s10620-009-1051-6. Epub 2009 Dec 4.

Abstract

BACKGROUND

So far, the miRNAs involved in multidrug resistance of esophageal cancer have not been reported.

AIMS AND METHODS

Here we have firstly investigated the roles of miR-27a in multidrug resistance of esophageal squamous cell carcinoma using MTT assay, flow cytometry assay, and reporter gene assay, etc.

RESULTS

Down-regulation of miR-27a could confer sensitivity of both P-glycoprotein-related and P-glycoprotein-non-related drugs on esophageal cancer cells, and might promote ADR-induced apoptosis, accompanied by increased accumulation and decreased releasing amount of ADR. Down-regulation of miR-27a could significantly decrease the expression of P-glycoprotein, Bcl-2, and the transcription of the multidrug resistance gene 1, but up-regulate the expression of Bax.

CONCLUSIONS

MiR-27a might play important roles in multidrug resistance of esophageal cancer. The further study of the biological functions of miR-27a might be helpful for developing possible strategies to treat esophageal cancer.

摘要

背景

目前,涉及食管癌多药耐药的 miRNA 尚未见报道。

目的与方法

本研究采用 MTT 法、流式细胞术和报告基因等方法,首次探讨了 miR-27a 在食管鳞癌细胞多药耐药中的作用。

结果

下调 miR-27a 可增加 P-糖蛋白相关和非相关药物对食管癌细胞的敏感性,并可能促进 ADR 诱导的细胞凋亡,同时增加 ADR 的蓄积和减少释放。下调 miR-27a 可显著降低 P-糖蛋白、Bcl-2 的表达和多药耐药基因 1 的转录,同时上调 Bax 的表达。

结论

miR-27a 可能在食管癌多药耐药中发挥重要作用。对 miR-27a 生物学功能的进一步研究可能有助于开发治疗食管癌的可能策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验